Description

Retatrutide (RETA) is an advanced investigational triple-agonist peptide that simultaneously targets the GLP-1, GIP, and glucagon receptors — three critical pathways involved in appetite control, insulin sensitivity, and lipid metabolism.

Key Research Features

• Triple agonist peptide studied for metabolic regulation
• Targets GLP-1, GIP, and glucagon receptor pathways simultaneously
• Investigated for appetite suppression and fat loss applications
• Potential to support insulin sensitivity and glucose homeostasis

Specifications

• Purity: >99% Research Grade
• Form: Lyophilized Powder
• CAS Number: 2381089-83-2
• Storage: 2-8C, freeze at -20C long-term

For Research Use Only.